glp 1 and graves disease Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality TSH Levels GLP-1 Receptor Agonists and Thyroid

Unlike RWD, RCT data aims to assess the efficacy and safety of an intervention

Transport of beta-alanine and biosynthesis of carnosine by skeletal-muscle cells in primary culture

Flaxseed, an excellent source of omega fatty acids, has been shown to decrease serum glucose and insulin levels in overweight/obese individuals with pre-diabetes after 12 weeks of consumption [116, 121]

Tirzepatide, a dual glucagon-like peptide-1 (GIP) and GLP-1RAs, administered once weekly at a 15 mg dose, resulted in an average weight loss of 20.9% over 72 weeks (Jastreboff et al., 2022), driven by its synergistic effects on appetite regulation, energy intake reduction, and fat mass decrease (Heise et al., 2023)